A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [72]
In the citing paper
“This association has been replicated either directly or using highly correlated SNPs by several groups (92–97).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“The replicated nicotine dependence loci tagged by rs16969968 (96,100–102) and rs578776 (101,103) have also been reported to influence lung cancer risk in several genome-wide association studies.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“This second association with nicotine dependence has been replicated in additional studies using the same SNP or a highly correlated SNP (92,95,96,98).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationGenotype-environment interaction and correlation in the analysis of human behavior.
Plomin, R., DeFries, J. C., & Loehlin, J. C. (1977) · Psychological Bulletin · doi:10.1037/0033-2909.84.2.309 · Cited by 1,685
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Cited by
Items 601–700 of 1,002
DeYoung, C. G., & Blain, S. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.026 · Cited by 38
Gao, F., Xiong, X., Pan, W., Yang, X., Zhou, C., Yuan, Q., Zhou, L., & Yang, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135647 · Cited by 37
Qiu, J., Ma, Y., Chen, L., Wu, L., Wen, Y., & Liu, W. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3353-9 · Cited by 35
“As is well known, nicotine not only imperils the health of human beings and the ecological balance but also pollutes the environment (Schievelbein 1982; Civilini et al. 1997; Thorgeirsson et al. 2008).”
BackgroundBoscarino, J. A. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.01.001 · Cited by 38
Variation in TP63 is Associated with Lung Adenocarcinoma in the UK Population
Wang, Y., Broderick, P., Matakidou, A., Vijayakrishnan, J., Eisen, T., & Houlston, R. S. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0042 · Cited by 35
“1 (CHRNA5CHRNA3-CHRNA4) influences lung cancer risk in European populations(3-7).”
BackgroundGenetic Epidemiology of Smoking Behavior and Nicotine Dependence
Kaprio, J. (2009) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049165 · Cited by 35
“Nonetheless, this chromosome 15 finding only accounts for a small fraction of the genetic risk in nicotine dependence, as it accounts for only 1% of the variance in amount smoked, with persons having the risk and non-risk homozygote genotypes differing in average cigarette consumption by only two cigarettes per day (7…”
BackgroundOkazaki, I., Ishikawa, S., Ando, W., & Sohara, Y. (2016) · Anticancer Research · doi:10.21873/anticanres.11215 · Cited by 38
Tobacco Smoke Carcinogens and Lung Cancer
Hecht, S. S. (2010) · Humana Press eBooks · doi:10.1007/978-1-61737-995-6_3 · Cited by 44
Wassel, C. L., Lamina, C., Nambi, V., Coassin, S., Mukamal, K. J., Ganesh, S. K., Jacobs, D. R., Franceschini, N., Papanicolaou, G., Gibson, Q., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.039 · Cited by 37
“TCF7L2 is the strongest genetic risk factor for susceptibility to type 2 diabetes [22–25] and CYP2B6 affects smoking behavior [26] and thus may be important in tobacco-related diseases such as PAD.”
BackgroundSelf-citationBoscarino, J. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.003 · Cited by 39
Mesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Imai, Y., Kusano, K., Aiba, T., Ako, J., Asano, Y., Harada‐Shiba, M., Kataoka, M., Kosho, T., Kubo, T., Matsumura, T., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0926 · Cited by 38
Propensity for social interaction predicts nicotine‐reinforced behaviors in outbred rats
Wang, T., Han, W., Wang, B., Jiang, Q., Solberg‐Woods, L., Palmer, A. A., & Chen, H. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12112 · Cited by 38
“Genome-wide studies have found that variants of many genes, such as the CHRNA5CHRNA3-CHRNB4 cluster (Chen et al. 2012b; Saccone et al. 2009; Thorgeirsson et al. 2008, 2010), CYP2A6 (Siedlinski et al. 2011; Thorgeirsson et al. 2010) and brain-derived neurotrophic factor (Tobacco and Genetics…”
BackgroundHancock, D. B., Wang, J., Gaddis, N., Levy, J. L., Saccone, N. L., Stitzel, J. A., Goate, A., Bierut, L. J., & Johnson, E. O. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv303 · Cited by 37
Nicotinic receptors and nicotine addiction
Changeux, J. (2009) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2009.02.005 · Cited by 37
“Remarkably, three independent epidemiological studies this year have highlighted the importance of three genes encoding subunits of the nicotinic receptor as predisposing to lung cancer: alpha3, alpha5 and beta4 [21].”
BackgroundIshii, T., Hagiwara, K., Ikeda, S., Arai, T., Mieno, M., Kumasaka, T., Muramatsu, M., Sawabe, M., Gemma, A., & Kida, K. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.676110 · Cited by 39
ASCL1 Regulates the Expression of the CHRNA5/A3/B4 Lung Cancer Susceptibility Locus
Improgo, M. R., Schlichting, N. A., Cortes, R. Y., Zhao-Shea, R., Tapper, A. R., & Gardner, P. D. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0185 · Cited by 38
“Our observation that the nAChR α3, α5, and β4 subunit genes are overexpressed in SCLC is particularly intriguing in light of the recent genome-wide association studies implicating the CHRNA5/A3/B4 gene locus in lung cancer susceptibility (20-23).”
BackgroundA rare missense mutation in CHRNA4 associates with smoking behavior and its consequences
Thorgeirsson, T. E., Steinberg, S., Reginsson, G. W., Bjornsdottir, G., Rafnar, T., Jonsdottir, I., Helgadottir, A., Gretarsdottir, S., Helgadottir, H., Jonsson, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.13 · Cited by 33
“Furthermore, as was the case for CHRNA5 (refs 2,31,32) the observed effect on FTND and CPD alone is not expected to fully explain the observed OR for smoking-related diseases.”
BackgroundSelf-citationThe α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors
Scholze, P., & Huck, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.607959 · Cited by 39
“, 2019) and variants at the CHRNA5/CHRNA3/CHRNB4 gene locus on chromosome 15q25 (Bierut et al., 2008; Stevens et al., 2008; Thorgeirsson et al., 2008; Improgo et al., 2010; Tuesta et al., 2011; Berrettini and Doyle, 2012; Slimak et al., 2014; Lassi et al., 2016; Forget et al., 2018; Besson et al., 2019; Maskos, 2020).”
BackgroundGenetic Determinants of Peripheral Artery Disease
Klarin, D. M., Tsao, P. S., & Damrauer, S. M. (2021) · Circulation Research · doi:10.1161/circresaha.121.318327 · Cited by 35
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 41
Lung Cancer Genomic Signatures
Agulló-Ortuño, M. T., López‐Ríos, F., & Paz-Ares, L. G. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f1900e · Cited by 36
Pharmacogenetics of Chronic Obstructive Pulmonary Disease: Challenges and Opportunities
Hersh, C. P. (2010) · Pharmacogenomics · doi:10.2217/pgs.09.176 · Cited by 33
Snetselaar, R., van Oosterhout, M. F. M., Grutters, J. C., & van Moorsel, C. H. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00041 · Cited by 34
Ben‐Eliyahu, A., & Zeidner, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.041 · Cited by 34
Elliott, K. S., Zeggini, E., McCarthy, M. I., Guðmundsson, J., Sulem, P., Stacey, S., Thorlacius, S., Amundadottir, L. T., Grönberg, H., Xu, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010858 · Cited by 36
“Investigators who agreed to participate in the collaborative analysis contributed data on 13 datasets for rs4430796 and 19 datasets for rs7501939 [11,17,18,19, 20,21,22,23,24,25,26,27,28,29,30,31,32,33].”
BackgroundMethodSelf-citationNicotine-mediated signals modulate cell death and survival of T lymphocytes
Oloris, S. C. S., Frazer‐Abel, A. A., Jubala, C. M., Fosmire, S. P., Helm, K. M., Robinson, S. R., Korpela, D. M., Duckett, M. M., Baksh, S., & Modiano, J. F. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.020 · Cited by 34
“Recently, four independent genome wide association studies found that the risk of lung cancer in smokers was strongly associated with a marker in chromosome 15 that is coincident with the α3-nAChR subunit (Amos et al., 2008; Berrettini et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008), which partners with th…”
BackgroundInfluentialUsing Mendelian randomisation to infer causality in depression and anxiety research
Gage, S. H., Smith, G. D., Zammit, S., Hickman, M., & Munafò, M. R. (2013) · Depression and Anxiety · doi:10.1002/da.22150 · Cited by 32
“[29] The following year, a genome wide association study (GWAS) provided more robust evidence for an association between this region and smoking behaviour.[30] More recently other loci have begun to be identified via GWAS,[31, 32] but the chromosome 15 signal remains the strongest and most robust signal observed to da…”
BackgroundSmoking and psychopathology increasingly associated in recent birth cohorts
Talati, A., WICKRAMARATNE, P. J., Keyes, K. M., Hasin, D. S., LEVIN, F. R., & Weissman, M. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.025 · Cited by 34
Update in Lung Cancer and Mesothelioma 2012
Powell, C. A., Halmos, B., & Nana-Sinkam, S. P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0716up · Cited by 34
“1, which harbors subunits for the nicotinic acetylcholine receptor that are associated with tobacco dependence and lung cancer risk (63, 64).”
BackgroundBarrie, E. S., Hartmann, K., Lee, S., Frater, J. T., Seweryn, M. T., Wang, D., & Sadée, W. (2016) · Human Mutation · doi:10.1002/humu.23135 · Cited by 39
“1), implicated in clinical phenotypes including nicotine dependence [Saccone et al., 2007; Thorgeirsson et al., 2008; Liu et al., 2010; Saccone et al., 2010; Thorgeirsson and Stefansson 2010; Tobacco and Genetics Consortium 2010] and smoking-related disorders [Amos et al., 2008; Hung et al., 2008;…”
BackgroundInfluentialZhou, H., Cheng, Z., Bass, N. J., Krystal, J. H., Farrer, L. A., Kranzler, H. R., & Gelernter, J. E. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0258-8 · Cited by 33
Hopkins, R. J., Duan, F., Gamble, G. D., Chiles, C., Cavadino, A., Billings, P. R., Aberle, D. R., & Young, R. P. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-214839 · Cited by 32
Verhagen, M., Kleinjan, M., & Engels, R. C. M. E. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.76 · Cited by 36
Genetics of biologically based psychological differences
Sallis, H., Smith, G. D., & Munafo, M. R. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0162 · Cited by 35
Garcia‐Rivas, V., & Deroche‐Gamonet, V. (2018) · Addiction Biology · doi:10.1111/adb.12607 · Cited by 33
“In particular, a SNP in the rs16969968 allele of the CHRNA5 gene has been associated with smoking that is heavy, out of control, and manifests in strong craving (Saccone et al. 2007; Thorgeirsson et al. 2008; Chen et al. 2012; Gabrielsen et al. 2013).”
BackgroundCommentary: Gene-environment interactions and smoking-related cancers
Thorgeirsson, T. E., & Stefánsson, K. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp385 · Cited by 32
Self-citationMcEachin, R. C., Saccone, N. L., Saccone, S. F., Kleyman-Smith, Y. D., Kar, T., Kare, R. K., Ade, A. S., Sartor, M. A., Cavalcoli, J. D., & McInnis, M. G. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-14 · Cited by 31
“This is consistent with gender differences seen in some studies of TUD susceptibility, though there are also genetic findings for TUD that have consistent effects in both genders [40,83-85].”
ResultSequence variants affecting the genome-wide rate of germline microsatellite mutations
Kristmundsdóttir, S., Jónsson, H., Hardarson, M. T., Pálsson, G., Beyter, D., Eggertsson, H. P., Gylfason, A., Sveinbjörnsson, G., Holley, G., Stefánsson, Ó. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39547-6 · Cited by 34
Self-citationLimits to forecasting in personalized medicine: An overview
Ioannidis, J. P. A. (2009) · International Journal of Forecasting · doi:10.1016/j.ijforecast.2009.05.003 · Cited by 35
Association of CHRNA4 polymorphisms with smoking behavior in two populations
Han, S., Yang, B., Kranzler, H. R., Oslin, D., Anton, R., & Gelernter, J. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31177 · Cited by 31
Lubke, G. H., Stephens, S. H., Lessem, J. M., Hewitt, J. K., & Ehringer, M. A. (2012) · Behavior Genetics · doi:10.1007/s10519-012-9529-y · Cited by 32
Mu, R., Liu, H., Luo, S., Patz, E. F., Glass, C., Su, L., Du, M., Christiani, D. C., Jin, L., & Wei, Q. (2021) · International Journal of Cancer · doi:10.1002/ijc.33702 · Cited by 31
Gelernter, J. E., & Kranzler, H. R. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/jgelernter · Cited by 34
‘Two-faces’ of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment
Liu, Y., Li, L., Wang, L., Lu, L., Li, Y., Huang, G., & Song, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00618-1 · Cited by 35
“Tumourigenesis attributes to various genetic mutations, one of the important mutation types is the deletion of the coding region in chromosomes which is highly related to the occurrence of tumor [97].”
BackgroundWang, Y., Wei, Y., Gaborieau, V., Shi, J., Han, Y., Timofeeva, M. N., Su, L., Li, Y., Eisen, T., Amos, C. I., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.48 · Cited by 34
Genetic evidence linking lung cancer and COPD: a new perspective
Young, R. P., Hopkins, R. J., Gamble, G. D., Etzel, C., Randa, E.-Z., & Crapo, J. D. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s20083 · Cited by 36
Chikova, A. K., & Grando, S. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027978 · Cited by 31
“nicotine dependence and lung cancer [1,2,3].”
Association of Neurexin 3 polymorphisms with smoking behavior
Docampo, E., Ribasés, M., Gratacòs, M., Bruguera, E., Cabezas, C., Sánchez‐Mora, C., Nieva, G., Puente, D., Argimon-Pallàs, J. M., Casas, M., et al. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00815.x · Cited by 32
Usui, K., Ushijima, T., Tanaka, Y., Tanai, C., Noda, H., Abe, N., Horiuchi, H., & Ishihara, T. (2011) · Pulmonary Medicine · doi:10.1155/2011/290132 · Cited by 31
Ward-Caviness, C. K., Neas, L., Blach, C., Haynes, C. S., Larocque-Abramson, K. R., Grass, E. A., Dowdy, E., Devlin, R. B., Díaz-Sánchez, D., Cascio, W. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152670 · Cited by 34
“In a 2008 study, a genetic variant in a gene cluster linked to smoking behavior was also linked to PAD and lung cancer [18].”
BackgroundKapoor, M., Wang, J., Bertelsen, S. E., Bucholz, K. K., Budde, J., Hinrichs, A. L., Agrawal, A., Brooks, A. I., Chorlian, D. B., Dick, D. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033513 · Cited by 35
“Genome wide association studies (GWAS) and candidate gene studies of nicotine dependence have identified several variants in the gene cluster encoding the a5, a3, and b4 nicotinic receptor subunits on chromosome 15 that alter risk for nicotine dependence, including an amino acid substitution (aspartic acid to asparagi…”
BackgroundCumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer
Liu, P., Vikis, H. G., Lü, Y., Wang, Y., Schwartz, A. G., Pinney, S. M., Yang, P., de Andrade, M., Gazdar, A. F., Gaba, C., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0791 · Cited by 33
“1 region has been recently reported to be associated with both familial and sporadic lung cancer (8-10, 12).”
BackgroundLang, B. M., Biedermann, L., van Haaften, W. T., de Vallière, C., Schuurmans, M. M., Begré, S., Zeitz, J., Scharl, M. M., Turina, M., Greuter, T., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14378 · Cited by 31
Older Smokers' Motivation and Attempts to Quit Smoking
Breitling, L. P., Rothenbacher, D., Stegmaier, C., Raum, E., & Brenner, H. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0451 · Cited by 40
“That they are unable to give up smoking despite their concurrent disease makes a mockery of the assertion that smoking is primarily a lifestyle phenomenon—an assertion which anyway is contradicted by the rapidly increasing knowledge of genetic risk factors in smoking and tobacco dependency (13, 14).”
BackgroundUtility of genetically modified mice for understanding the neurobiology of substance use disorders
Fowler, C. D., & Kenny, P. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1129-z · Cited by 34
A Review of Cancer Risk Prediction Models with Genetic Variants
Wang, X., Oldani, M. J., Zhao, X., Huang, X., & Qian, D. (2014) · Cancer Informatics · doi:10.4137/cin.s13788 · Cited by 33
Xie, K., Chen, M., Zhu, M., Wang, C., Qin, N., Liang, C., Song, C., Dai, J., Jin, G., Shen, H., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30788 · Cited by 31
Hung, Y., & Hung, W. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.042 · Cited by 31
A review on non-small cell lung cancer
Verma, S. K., Pandey, M., Khare, R., & Singh, D. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacun.2023.12.003 · Cited by 32
Mathews, R. R. S., Hall, W., & Carter, A. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03836.x · Cited by 33
“4 times more likely to develop nicotine dependence than those without [12].”
BackgroundCui, K., Ge, X., & Ma, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102324 · Cited by 31
Qian, D. C., Han, Y., Byun, J., Shin, H. R., Hung, R. J., McLaughlin, J. R., Landi, M. T., Seminara, D., & Amos, C. I. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1318 · Cited by 30
Icick, R., Forget, B., Cloëz-Tayarani, I., Pons, S., Maskos, U., & Besson, M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108234 · Cited by 31
Effect of the Rs1051730–Rs16969968 Variant and Smoking Cessation Treatment: A Meta-Analysis
Leung, T., Bergen, A. W., Munafo, M. R., Ruyck, K. D., Selby, P. L., & Luca, V. D. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.34 · Cited by 31
Zhang, H., Kranzler, H. R., Poling, J. C., & Gelernter, J. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.95 · Cited by 32
“…the CHRNA5– CHRNA3–CHRNB4 gene cluster contributes to risk for lung cancer (Hung et al, 2008; Amos et al, 2008; Thorgeirsson et al, 2008), peripheral arterial disease (Thorgeirsson et al, 2008), or nicotine dependence (ND; Hung et al, 2008; Thorgeirsson et al, 2008; Berrettini et al, 2008).”
BackgroundNeuroimaging, genetics and the treatment of nicotine addiction
Ray, R., Loughead, J., Wang, Z., Detre, J. A., Yang, E., Gur, R. C., & Lerman, C. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.021 · Cited by 29
Nature, nurture and socioeconomic policy—What can we learn from molecular genetics?
Lundborg, P., & Stenberg, A. (2010) · Economics & Human Biology · doi:10.1016/j.ehb.2010.08.002 · Cited by 34
Wang, J., Spitz, M. R., Amos, C. I., Wu, X., Wetter, D. W., Cinciripini, P. M., & Shete, S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047705 · Cited by 30
“Thus, there is a debate about whether the genetic variants have an impact on lung cancer risk directly or exert their effect largely through the profound effect of the variants on smoking intensity [20–22] or COPD [23].”
BackgroundPark, S. L., Caberto, C., Lin, Y., Goodloe, R., Dumitrescu, L. C., Love, S.-A. M., Matise, T. C., Hindorff, L. A., Fowke, J. H., Schumacher, F. R., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0129 · Cited by 31
“Variants within this region have been associated with increased risk of lung cancer primarily due to their relationships with smoking behavior and nicotine dependence(15, 81, 82, 88).”
Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S.
Tu, H., Heymach, J. V., Wen, C.-P., Ye, Y., Pierzynski, J. A., Roth, J. A., & Wu, X. (2016) · Scientific Reports · doi:10.1038/srep26760 · Cited by 30
Saccone, N. L., Emery, L. S., Sofer, T., Gogarten, S. M., Becker, D. M., Böttinger, E. P., Chen, L.-S., Culverhouse, R., Duan, W., Hancock, D. B., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx107 · Cited by 32
Development of pluripotent stem cells for vascular therapy
Volz, K. S., Miljan, E., Khoo, A., & Cooke, J. P. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.010 · Cited by 30
“Smoking, diabetes, hypertension, dyslipidemia and sedentary nature contribute to the development of PAD, superimposed upon a genetic predisposition (Leeper et al., 2010; Thorgeirsson et al., 2008; Wilson et al., 2011).”
BackgroundYu, H., Zhao, H., Wang, L., Han, Y., Chen, W. V., Amos, C. I., Rafnar, Þ., Sulem, P., Stefánsson, K., Landi, M. T., et al. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.01.005 · Cited by 30
“31 [22–28].”
BackgroundSelf-citationAssociation Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis
Zhu, K., Xu, A., Xia, W., Li, P., Zhang, B., Jiang, H., Zhou, S., & Wang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.567762 · Cited by 28
“The current view is that the occurrence and development of lung cancer is the result of the interaction between environment and heredity (4, 5).”
BackgroundByun, J., Han, Y., Ostrom, Q. T., Edelson, J. L., Walsh, K. M., Pettit, R. W., Bondy, M. L., Hung, R. J., McKay, J., & Amos, C. I. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1635 · Cited by 33
Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk
Wei, R., DeVilbiss, F. T., & Liu, W. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.08.005 · Cited by 28
Robles, A. I., Yang, P., Jen, J., McClary, A. C., Calhoun, K. M., Bowman, E. D., Vähäkangas, K., Greathouse, K. L., Wang, Y., Olivo‐Marston, S., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0158 · Cited by 29
“In addition, several genome-wide association studies (GWAS) of lung cancer have identified a significant lung cancer susceptibility locus at cytoband 15q25, especially in early-onset smokers (9, 11, 12).”
BackgroundCurious cases: Altered dose–response relationships in addiction genetics
Uhl, G. R., Drgonová, J., & Hall, F. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.013 · Cited by 28
“By contrast, as influences of nicotine quantity/ frequency are statistically removed, associations between variants in this α5/α3 nicotinic receptor locus and DSM nicotine dependence (or with more physiological nicotine dependence defined using the Fagerström Test of Nicotine Dependence (FTND)) are weakened substantia…”
BackgroundExternalizing Behaviors are Associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster
Stephens, S. H., Hoft, N. R., Schlaepfer, I. R., Young, S. E., Corley, R., McQueen, M. B., Hopfer, C. J., Crowley, T. J., Stallings, M. C., Hewitt, J. K., et al. (2011) · Behavior Genetics · doi:10.1007/s10519-011-9514-x · Cited by 34
Adult mice voluntarily progress to nicotine dependence in an oral self-selection assay
Locklear, L. L., McDonald, C. G., Smith, R. F., & Fryxell, K. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.037 · Cited by 28
Nicotine dependence may link the 15q25 locus to lung cancer risk
Galvan, A., & Dragani, T. A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp282 · Cited by 29
Genome-Wide Significant Association Between a Sequence Variant at 15q15.2 and Lung Cancer Risk
Rafnar, Þ., Sulem, P., Besenbacher, S., Gudbjartsson, D. F., Zanon, C., Guðmundsson, J., Stacey, S., Kostic, J. P., Thorgeirsson, T. E., Þorleifsson, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2852 · Cited by 31
“The Icelandic lung cancer study population was previously described (6).”
Self-citationLiu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 34
“The most compelling human genetic associations with NA are located in chromosomal region 15q25, which encompasses the α5-α3-β4 nAChR subunit gene cluster (CHRNA5-CHRNA3-CHRNB4) [103, 104] and on chromosome 8, in the region encompassing the β3–α6 nAChR subunit gene cluster (CHRNB3-CHRNA6) [105]. nAChR subunits also pla…”
BackgroundWang, T., Han, W., Chitre, A. S., Polesskaya, O., Woods, L. C. S., Palmer, A. A., & Chen, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-36263-w · Cited by 30
Is Schizophrenia a Risk Factor for Breast Cancer?—Evidence From Genetic Data
Byrne, E. M., Ferreira, M. A. R., Xue, A., Lindström, S., Jiang, X., Yang, J., Easton, D. F., Wray, N. R., & Chenevix‐Trench, G. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby162 · Cited by 29
Conlon, M. S., & Bewick, M. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr140 · Cited by 31
Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors
Flora, A. V., Zambrano, C. A., Gallego, X., Miyamoto, J. H., Johnson, K. A., Cowan, K. A., Stitzel, J. A., & Ehringer, M. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.017 · Cited by 27
Greenbaum, L., Rigbi, A., Lipshtat, N., Cilia, R., Tesei, S., Asselta, R., Djaldetti, R., Goldwurm, S., & Lerer, B. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.007 · Cited by 30
The Galanin Receptor 1 Gene Associates with Tobacco Craving in Smokers Seeking Cessation Treatment
Lori, A., Tang, Y., O’Malley, S. S., Picciotto, M. R., Wu, R., Conneely, K. N., & Cubells, J. F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.25 · Cited by 31
Nees, F., Witt, S. H., Lourdusamy, A., Vollstädt‐Klein, S., Steiner, S., Poustka, L., Banaschewski, T., Barker, G. J., Büchel, C., Conrod, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.131 · Cited by 30
“…reserved 0893-133X/13 www.neuropsychopharmacology.org the CHRNA5–CHRNA3–CHRNB4 cluster of cholinergic nicotinic receptor subunit genes in both smoking and ND (Saccone et al, 2007; Bierut et al, 2008; Thorgeirsson et al, 2008, 2010; The Tobacco and Genetics Consortium (TAG) (2010); Liu et al, 2010).”
BackgroundTromp, G., & Kuivaniemi, H. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.08.010 · Cited by 27
Murphy, S. E., von Weymarn, L. B., Schutten, M. M., Kassie, F., & Modiano, J. F. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0366 · Cited by 30
Genetics of Smoking Behavior and Its Consequences: The Role of Nicotinic Acetylcholine Receptors
Thorgeirsson, T. E., & Stefánsson, K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.010 · Cited by 31
Self-citationGenetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor
Lü, Y., Liu, P., James, M. A., Vikis, H. G., Liu, H., Wu, W., Franklin, A. D., & You, M. (2009) · Oncogene · doi:10.1038/onc.2009.396 · Cited by 30
“33 with lung cancer susceptibility (Amos et al., 2008; Hung et al., 2008; Liu et al., 2008; McKay et al., 2008; Thorgeirsson et al., 2008; Wang et al., 2008; Rafnar et al., 2009).”
Significant association of 5p15.33 (TERT–CLPTM1Lgenes) with lung cancer in Chinese Han population
Zhao, Z., Li, C., Yang, L., Zhang, X., Zhao, X., Song, X., Li, X., Wang, J., Qian, J., Yang, Y., et al. (2013) · Experimental Lung Research · doi:10.3109/01902148.2012.762436 · Cited by 26
Maskos, U. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14989 · Cited by 28
“…positive allosteric modulator, schizophrenia, single nucleotide polymorphism et al., 2019), lung cancer (Amos et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008), chronic obstructive pulmonary disease (Busch et al., 2017; Pillai et al., 2009; Wilk et al., 2012) and lung function…”
BackgroundHusson, M., Harrington, L., Tochon, L., Cho, Y. H., Ibáñez-Tallon, I., Maskos, U., & David, V. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0356-19.2020 · Cited by 29
“…gene cluster, in which genetic variants have been linked to high predisposition to nicotine dependence in humans (Amos et al., 2008; Thorgeirsson et al., 2008; Weiss et al., 2008; Saccone et al., 2009). b4*nAChRs are almost exclusively expressed in the medial habenula (MHb), its…”
BackgroundReisenzein, R., Hildebrandt, A., & Weber, H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.009 · Cited by 37
Lee, D., Lee, G. K., Yoon, K., & Lee, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065396 · Cited by 32
“Finally, we added genes covered in lung cancer susceptibility loci reported in several previous GWA studies: C3ORF21 and TP63 from 3q28-29 [11,44], TERT and CLPTM1L from 5p15 [5,7], BAT and MSH5 from 6p21 [7], CHRNA5, CHRNA4, and CHRNA3 from 15q25 [8–10], and DNA repair genes (XRCC1, RRM1, ERCC1) [45].”
BackgroundMethod
Metadata
- Authors
- Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsäter, A., Flex, A., Aben, K. K. H., de Vegt, F., Mulders, P. F. A., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- University of Otago (NZ)
- Convent Hospital of the Brothers of Saint John of God (AT)
- Skåne University Hospital (SE)
- Università Cattolica del Sacro Cuore (IT)
- Radboud University Medical Center (NL)
- Hospital Universitario Reina Sofía (ES)
- National University Hospital of Iceland (IS)
- Instituto de Nanociencia y Materiales de Aragón (ES)
- Corresponding author
- Thorgeirsson, Thorgeir E.
- ORCID
- Venue
- Nature
- Published
- 2008-04
- Volume
- 452
- Issue
- 7187
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4539558
- OpenAlex
- W2118082971
- Cited by
- 1,523
- References
- 45
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 29 · 2023: 41 · 2022: 33 · 2021: 36 · 2020: 94 · 2019: 48 · 2018: 56 · 2017: 79 · 2016: 80 · 2015: 107 · 2014: 91 · 2013: 100 · 2012: 145
- FWCI
- 120.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- European Commission
- National Institute on Drug Abuse (R01DA017932)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotinic acetylcholine receptors, nicotine dependence, smoking quantity, lung cancer susceptibility, peripheral arterial disease, gene-environment interaction, genetic susceptibility, smoking-related diseases
- MeSH terms
- Chromosomes, Human, Pair 15, Europe, Female, Multigene Family, Genotype, Humans, Lung Neoplasms, Male, New Zealand, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Odds Ratio, Peripheral Vascular Diseases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.